Embryonic abnormalities at medical termination of pregnancy

Embryonic abnormalities at medical termination of pregnancy with mifepristone and misoprostol during first trimester: observational study.

The availability of new medical techniques for induced abortion in the first trimester enables observation of the incidence and nature of embryonic and fetal abnormalities in early pregnancy. 506 women, presenting to the Liverpool (England) Women's Hospital in 1994-96 for induced abortion before 9 weeks of gestation, were given oral mifepristone followed by oral misoprostol. Fetal tissue was ...

Termination of Pregnancy with Prostaglandin

تاثیر تزریق داخل رحمی apGF2 و تزریق داخل وریدی اکسی توسین به عنوان دو روش درمانی در ختم حاملگی، در زنانی که در سه ماهه دوم بارداری دچار پارگی کیسه آب بودند، با یک دیگر مقایسه شده اند.

The Medical Termination of Pregnancy Act.

Termination of Pregnancy for Medical Indications

Background Following the legal provisions on the termination of pregnancies in Art. 13 of the SFHG (Law on the Assistance for Pregnant Women and Families, passed on 27.07.1992, BGBl. I, p. 1398) the socalled embryopathic indication for termination was abandoned. Since then, sec. 218a para. 2 of the German Criminal Code (StGB) states that for late terminations, i.e., terminations after the 12th ...

Misoprostol Alone or in Combination with Methotrexate for Termination of Pregnancy at First Trimester

Abortion is an important problem in obstetrics throughout the world. The common and standard method for pregnancy termination at first trimester is surgery (curettage). Nowadays, an effective method of pregnancy termination at first trimester is medical treatments. The aim of this study is to compare misoprostol alone or in combination with methotrexate for pregnancy termination at first trimes...